Lindsey Rolfe

2019

In 2019, Lindsey Rolfe earned a total compensation of $2.7M as EVP of Clinical and Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology, a 48% increase compared to previous year.

Compensation breakdown

Bonus$240,553
Option Awards$380,788
Salary$504,656
Stock Awards$1,544,691
Other$14,822
Total$2,685,510

Rolfe received $1.5M in stock awards, accounting for 58% of the total pay in 2019.

Rolfe also received $240.6K in bonus, $380.8K in option awards, $504.7K in salary and $14.8K in other compensation.

Rankings

In 2019, Lindsey Rolfe's compensation ranked 4,547th out of 13,971 executives tracked by ExecPay. In other words, Rolfe earned more than 67.5% of executives.

ClassificationRankingPercentile
All
4,547
out of 13,971
68th
Division
Manufacturing
1,696
out of 5,701
70th
Major group
Chemicals And Allied Products
593
out of 2,200
73rd
Industry group
Drugs
499
out of 1,886
74th
Industry
Pharmaceutical Preparations
376
out of 1,398
73rd

Pay ratio

Lindsey Rolfe's Pay$2,685,510
Median Employee's Pay$262,806
Pay Ratio

10

to 1

In 2019, the annual total compensation of Lindsey Rolfe was $2,685,510.

The annual total compensation of the median employee at Clovis Oncology was $262,806.

The ratio of Lindsey Rolfe's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 24, 2020.

Rolfe's colleagues

We found four more compensation records of executives who worked with Lindsey Rolfe at Clovis Oncology in 2019.

2019

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2019

Paul Gross

Clovis Oncology

General Counsel

2019

Daniel Muehl

Clovis Oncology

Chief Financial Officer

2019

Gillian Ivers-Read

Clovis Oncology

EVP and Chief Regulatory Officer

News

You may also like